Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using theemail support widget if the problem persists.
The following section summarizes insights on Jiangsu GDK Biotechnology Co Ltd's EV / Fwd Revenue:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to EV / Fwd Revenue in the valuation category include:
Measures the dollars in Enterprise Value for each dollar of revenue projected to be earned over the next twelve months.
Revenue Multiple, EV / Revenue, Sales Multiple, or EV / Sales is defined as:
EV / Revenue = Enterprise Value / Revenue
Applying this formula, Jiangsu Gdk Biological Technology’s EV / Fwd Revenue is calculated below:
Enterprise Value [ NA ]
(/) Revenue Forecast [ NA ]
(=) EV / Fwd Revenue [ 15.0x ]
A revenue multiple measures the dollars in Enterprise Value for each dollar of revenue.
Using Enterprise Value considers the claims on revenue (and the profit that it yields) of both debt and equity holders.
High profit margins are highly correlated with higher Revenue Multiples.
The tables below summarizes the trend in Jiangsu Gdk Biological Technology’s EV / Revenue over the next five years:
<tr>
<td>2026-12-31</td>
<td>NA</td>
<td>NA</td>
<td>15.0</td>
</tr>
<tr>
<td>2027-12-31</td>
<td>NA</td>
<td>NA</td>
<td>15.0</td>
</tr>
<tr>
<td>2028-12-31</td>
<td>NA</td>
<td>NA</td>
<td>15.0</td>
</tr>
<tr>
<td>2029-12-31</td>
<td>NA</td>
<td>NA</td>
<td>15.0</td>
</tr>
| Date | Enterprise Value | Revenue | EV / Fwd Revenue |
|---|---|---|---|
| 2025-12-31 | NA | NA | 15.0 |
Read more about enterprise value (ev) and revenue forecast
The chart above depicts the distribution of EV / Fwd Revenue for companies operating in the Healthcare Sector in the Developing economic region. Over 1,160 companies were considered in this analysis, and 1,120 had meaningful values. The average EV / Fwd Revenue of companies in the Sector is 4.3x with a standard deviation of 5.0x. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Jiangsu GDK Biotechnology Co Ltd's EV / Fwd Revenue of 15.0x ranks in the 95.3% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developing |
| Total Constituents | 1,166 |
| Included Constituents | 1,120 |
| Min | 0.2x |
| Max | 42.4x |
| Median | 2.7x |
| Mean | 4.3x |
| Standard Deviation | 5.0x |
You can find companies with similar EV / Fwd Revenue using this stock screener.